Oxford GlycoSciences Plc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford GlycoSciences Plc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (400)	3/14/2003 10:03:40 AM
From: nigel bates	Read Replies (1) of 469

"We are pleased that the OGS Board has withdrawn its recommendation of the CAT merger and encourage all OGS Shareholders to accept Celltech's all cash offer. In addition, those OGS shareholders who may wish to benefit from continued participation in the future of the U.K. biotech sector, or Celltech itself, will have the option of applying their cash proceeds as they see fit following the completion of our offer." I've been struggling to come up with a printable response to Fellner. However, Miljenko seems to have done so for me - Message 18699132

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next